Asset Details
Do you wish to reserve the book?
Association of lipoprotein‐associated phospholipase A2 mass with asymptomatic cerebral artery stenosis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Association of lipoprotein‐associated phospholipase A2 mass with asymptomatic cerebral artery stenosis
Do you wish to request the book?
Association of lipoprotein‐associated phospholipase A2 mass with asymptomatic cerebral artery stenosis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Association of lipoprotein‐associated phospholipase A2 mass with asymptomatic cerebral artery stenosis
2018
Overview
Cerebral artery stenosis (CAS) is the most important causes of ischaemic stroke. Lipoprotein‐associated phospholipase A2 (Lp‐PLA2) plays 2 diverse roles in atherosclerosis (pro‐inflammatory and anti‐inflammatory), and the association between Lp‐PLA2 mass and cardiovascular or cerebrovascular events is inconsistent among previous studies. A cross‐sectional study including 2012 North Chinese adults aged ≥40 years was performed in 2010‐2011 to investigate whether Lp‐PLA2 mass is associated with asymptomatic cerebral artery stenosis (ACAS). Serum Lp‐PLA2 mass was determined by enzyme‐linked immunosorbent assay (ELISA). All participants underwent transcranial Doppler (TCD) and bilateral carotid duplex ultrasound to evaluate intracranial artery stenosis (ICAS) and extracranial arterial stenosis (ECAS). The median serum Lp‐PLA2 mass of the participants was 140.74 ng/mL (interquartile range: 131.79‐158.07 ng/mL). The adjusted odds ratio (OR) when comparing the 4th quartile to the 1st quartile of Lp‐PLA2 was 1.98 (95% confidence interval (CI): 1.42‐2.78), 1.79 (95% CI: 1.08‐2.94) and 1.87 (95% CI: 1.28‐2.73) for the occurrence of ACAS, asymptomatic ECAS and asymptomatic ICAS, respectively, after controlling for vascular risk factors. These independently significant associations remained statistically significant in the male or elderly subgroups, but not in females or middle‐aged participants. Lp‐PLA2 mass is positively correlated with subclinical atherosclerosis determined by ACAS, ICAS and ECAS in North Chinese, particularly in male and older participants, suggesting that serum Lp‐PLA2 mass might be potential biomarker for the detection of ACAS in the adults.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc
Subject
1-Alkyl-2-acetylglycerophosphocholine Esterase - blood
/ 1-Alkyl-2-acetylglycerophosphocholine Esterase - genetics
/ Adult
/ Aged
/ asymptomatic cerebral artery stenosis
/ Atherosclerosis - physiopathology
/ Brain Ischemia - physiopathology
/ Carotid Arteries - physiopathology
/ Cerebral Arteries - physiopathology
/ Constriction, Pathologic - blood
/ Constriction, Pathologic - genetics
/ Constriction, Pathologic - physiopathology
/ Diabetes
/ Enzyme-linked immunosorbent assay
/ Female
/ Genetic Predisposition to Disease
/ Humans
/ lipoprotein‐associated phospholipase A2 (Lp‐PLA2)
/ Male
/ Original
/ Stenosis
/ Stroke
